Sponsor Pipeline

Curis, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07271667 A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in… Chronic Lymphocytic Leukemia Recruiting
Phase 1/2
NCT03328078 CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in… Relapsed Hematologic Malignancy Recruiting
Disease Areas
Leukemia (1) Chronic Lymphocytic Leukemia (CLL) (1)
Get alerts when Curis, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free